216 related articles for article (PubMed ID: 21853341)
1. Expression and localization of four uroplakins in urothelial preneoplastic lesions.
Zupančič D; Zakrajšek M; Zhou G; Romih R
Histochem Cell Biol; 2011 Oct; 136(4):491-500. PubMed ID: 21853341
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
Zupančič D; Ovčak Z; Vidmar G; Romih R
Virchows Arch; 2011 May; 458(5):603-13. PubMed ID: 21301865
[TBL] [Abstract][Full Text] [Related]
3. Uroplakin gene expression by normal and neoplastic human urothelium.
Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
[TBL] [Abstract][Full Text] [Related]
4. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
Riedel I; Liang FX; Deng FM; Tu L; Kreibich G; Wu XR; Sun TT; Hergt M; Moll R
Eur J Cell Biol; 2005 Mar; 84(2-3):393-405. PubMed ID: 15819416
[TBL] [Abstract][Full Text] [Related]
5. Formation of asymmetric unit membrane during urothelial differentiation.
Sun TT; Zhao H; Provet J; Aebi U; Wu XR
Mol Biol Rep; 1996; 23(1):3-11. PubMed ID: 8983014
[TBL] [Abstract][Full Text] [Related]
6. SNX31: a novel sorting nexin associated with the uroplakin-degrading multivesicular bodies in terminally differentiated urothelial cells.
Vieira N; Deng FM; Liang FX; Liao Y; Chang J; Zhou G; Zheng W; Simon JP; Ding M; Wu XR; Romih R; Kreibich G; Sun TT
PLoS One; 2014; 9(6):e99644. PubMed ID: 24914955
[TBL] [Abstract][Full Text] [Related]
7. Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum.
Tu L; Sun TT; Kreibich G
Mol Biol Cell; 2002 Dec; 13(12):4221-30. PubMed ID: 12475947
[TBL] [Abstract][Full Text] [Related]
8. Uroplakins and cytokeratins in the regenerating rat urothelium after sodium saccharin treatment.
Romih R; Jezernik K; Masera A
Histochem Cell Biol; 1998 Mar; 109(3):263-9. PubMed ID: 9541475
[TBL] [Abstract][Full Text] [Related]
9. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases.
Kong XT; Deng FM; Hu P; Liang FX; Zhou G; Auerbach AB; Genieser N; Nelson PK; Robbins ES; Shapiro E; Kachar B; Sun TT
J Cell Biol; 2004 Dec; 167(6):1195-204. PubMed ID: 15611339
[TBL] [Abstract][Full Text] [Related]
10. Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking.
Hu CC; Liang FX; Zhou G; Tu L; Tang CH; Zhou J; Kreibich G; Sun TT
Mol Biol Cell; 2005 Sep; 16(9):3937-50. PubMed ID: 15958488
[TBL] [Abstract][Full Text] [Related]
11. Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly.
Deng FM; Liang FX; Tu L; Resing KA; Hu P; Supino M; Hu CC; Zhou G; Ding M; Kreibich G; Sun TT
J Cell Biol; 2002 Nov; 159(4):685-94. PubMed ID: 12446744
[TBL] [Abstract][Full Text] [Related]
12. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
[TBL] [Abstract][Full Text] [Related]
13. Involvement of vps33a in the fusion of uroplakin-degrading multivesicular bodies with lysosomes.
Guo X; Tu L; Gumper I; Plesken H; Novak EK; Chintala S; Swank RT; Pastores G; Torres P; Izumi T; Sun TT; Sabatini DD; Kreibich G
Traffic; 2009 Sep; 10(9):1350-61. PubMed ID: 19566896
[TBL] [Abstract][Full Text] [Related]
14. Urothelial plaque formation in post-Golgi compartments.
Hudoklin S; Jezernik K; Neumüller J; Pavelka M; Romih R
PLoS One; 2011; 6(8):e23636. PubMed ID: 21887288
[TBL] [Abstract][Full Text] [Related]
15. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants.
Li W; Liang Y; Deavers MT; Kamat AM; Matin SF; Dinney CP; Czerniak B; Guo CC
Am J Clin Pathol; 2014 Dec; 142(6):864-71. PubMed ID: 25389341
[TBL] [Abstract][Full Text] [Related]
16. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux.
Hu P; Deng FM; Liang FX; Hu CM; Auerbach AB; Shapiro E; Wu XR; Kachar B; Sun TT
J Cell Biol; 2000 Nov; 151(5):961-72. PubMed ID: 11085999
[TBL] [Abstract][Full Text] [Related]
17. MAL facilitates the incorporation of exocytic uroplakin-delivering vesicles into the apical membrane of urothelial umbrella cells.
Zhou G; Liang FX; Romih R; Wang Z; Liao Y; Ghiso J; Luque-Garcia JL; Neubert TA; Kreibich G; Alonso MA; Schaeren-Wiemers N; Sun TT
Mol Biol Cell; 2012 Apr; 23(7):1354-66. PubMed ID: 22323295
[TBL] [Abstract][Full Text] [Related]
18. Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells.
Wu XR; Medina JJ; Sun TT
J Biol Chem; 1995 Dec; 270(50):29752-9. PubMed ID: 8530366
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.
Osman I; Kang M; Lee A; Deng FM; Polsky D; Mikhail M; Chang C; David DA; Mitra N; Wu XR; Sun TT; Bajorin DF
Int J Cancer; 2004 Oct; 111(6):934-9. PubMed ID: 15300806
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma.
Zupancic D; Romih R
Radiol Oncol; 2013; 47(4):338-45. PubMed ID: 24294178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
